MFN changing the rules of the game for the Nordic countries
Innovative pharmaceutical trade associations across the Nordic region have reacted with vigilance to a recent report by GlobalData that highlighted…
All articles by Eoin Ryan
Eoin Ryan
-
-
Transformative arrival of oral weight loss medicines in the US
The arrival of the oral appetite suppressant drug Wegovy across 70,000 US pharmacies offers a more affordable and convenient weight-loss…
-
The threshold debate in Norway
The Norwegian pharmaceutical sector is preparing for long-awaited adjustments to the country’s cost-effectiveness willingness to pay (WTP) thresholds for medicines.…
-
Denmark’s HTA evolution
New health technology assessment (HTA) statistics produced by Denmark’s Medicine Council (Medicinrådet) for 2024 have prompted GlobalData to take the…
-
AIFA’s horizon scanning 2024 predictions suggest an influx of ATMPs
The mid-year period marks a significant phase for horizon scanning activities that map the regulatory approval progress of innovative medicines…
-
Patching the problem of EU drug shortages
The EU’s “Union list of critical medicines” stole many pharma-related headlines this week. Its publication is undoubtedly significant, but the…
-
EC’s proposed pharma reforms spark industry discontent
The recent legislative reform proposals put forward by the European Commission (EC) have sparked significant discontent among pharmaceutical companies. The…
-
Inflationary storm clouds will continue to buffet global pharma industry in 2023
While the threat of high inflation is receding, its second-round effects may not quickly abate. Pharma may have to navigate…
-
New dawn for the EU’s joint procurement crisis response
The European Union (EU) is on the cusp of approving clearer rules governing the joint procurement of medicines and medical…
-
How horizon scanning can help predict the future for EU’s Alzheimer’s disease market
Last year saw signs that the tide is beginning to turn for the approval of innovative Alzheimer’s disease (AD) medicines,…